Unicycive Therapeutics Inc. (UNCY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Unicycive Therapeutics In...

    NASDAQ: UNCY · Real-Time Price · USD
    4.09
    -0.20 (-4.66%)
    At close: Sep 11, 2025, 3:59 PM
    4.11
    0.49%
    After-hours: Sep 11, 2025, 06:43 PM EDT

    Unicycive Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 675K 951K n/a
    Cost of Revenue
    		 428K n/a 7K 1K
    Gross Profit
    		 -428K 675K 944K -1K
    Operating Income
    		 -32.12M -20.77M -18.05M -8.98M
    Interest Income
    		 1.26M 615K n/a 628K
    Pretax Income
    		 -37.82M -30.54M -18.06M -10.02M
    Net Income
    		 -36.73M -30.54M -18.06M -10.63M
    Selling & General & Admin
    		 12.1M 8.55M 6.57M 2.9M
    Research & Development
    		 20.01M 12.9M 12.44M 6.08M
    Other Expenses
    		 -428K n/a n/a n/a
    Operating Expenses
    		 31.69M 21.45M 19M 8.98M
    Interest Expense
    		 71K 82K 6K 628K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -32.12M 21.45M 19M 8.98M
    Income Tax Expense
    		 -1.09M n/a 6K 615K
    Shares Outstanding (Basic)
    		 66.99M 2.45M 1.51M 1.5M
    Shares Outstanding (Diluted)
    		 66.99M 2.45M 1.51M 1.5M
    EPS (Basic)
    		 -0.56 -1.28 -1.2 -0.71
    EPS (Diluted)
    		 -0.56 -1.28 -1.2 -0.71
    EBITDA
    		 -36.23M -30.18M -18.05M -8.98M
    EBIT
    		 -36.66M -30.46M -18.05M -8.98M
    Depreciation & Amortization
    		 428K 284K 7K 1K

    Add to Watchlist